One (1) capsule taken one (1) to three (3) times each day as a dietary supplement or as otherwise recommended by a healthcare professional
But most state and federally funded Medicaid programs dont cover the drugs for obesity and neither does Medicare, the federal program mainly for people age 65 and older
Jumping to higher doses too quickly dramatically increases the risk of severe nausea, vomiting, and other gastrointestinal side effects
View the BioOne 64oz Single Bottle Product Here
phase 3 trials ongoing as of 2025 Best phase 2 weight loss (retatrutide) / 24.2% at 48 weeks, 12 mg dose Best phase 3 weight loss (tirzepatide) / 22.5% at 72 weeks, 15 mg dose Combination evidence / zero published controlled trials Primary combination risk / additive nausea, vomiting, potential pancreatitis Switching rationale / inadequate response or tolerability on tirzepatide Guideline position on combining / no major guideline endorses dual-incretin stacking What Are Mounjaro and Retatrutide, and How Do They Differ
Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, et al